An expert panel explores the 2019 article on breast cancer risk and its implications for menopause management.
This recorded video is not a RACGP accredited activity. However, you can still complete the evaluation and receive a certificate for your own professional education records. Depending on your profession you may need to keep a record of some/all of the following: event date, provider, your learning needs in the area, the type of activity, content/details, learning outcomes, reflection on the activity, CPD hours.
Find out more on the CPD requirements of registered Australian health professions.
Health professional
The Lancet: Type and timing of menopausal hormone therapy and breast cancer risk
Jean Hailes for Women's Health
- MHT position statement
- ALM Managing menopause: weighing up the evidence
- Health professional tool: menopause
- Article: Menopause experts dismiss some breast cancer claims in new report
AMS Guide to Equivalent MHT/HRT Doses Australia only
AMS: Statement regarding the MHT and breast cancer risk, Lancet 2019 paper
Menopause hormone therapy: is there cause for concern
Patient information
Jean Hailes for Women's Health
- Menopause fact sheet
- Menopause fact sheet
Evaluation
This webinar is not eligible for RACGP QI&CPD points. To receive a certificate of completion complete the evaluation survey below.